Skip to main content
SpringerLink
Log in

Clinical Development of Perfluorocarbon-based Emulsions as Red Cell Substitutes

  • Chapter
Blood Substitutes

Abstract

The use of PFCs in medicine has been the subject of much research over the past 30 years. Recent technological progress in second generation oxygen transport products has solved many of the problems of Fluosol DA® including PFC concentration, elimination of surfactant side effects and improved storage stability. Some side effects, most notably, thrombocytopenia and flu-like symptoms still remain to be solved. Two new oxygen transport formulations, Oxyfluor™ and Oxygent™ are in clinical trials at this time. Several applications of PFCs have been approved for use by the FDA but have languished in the market place. Prominent among these is the application of Fluosol DA® to PTCA and Imagent GI for MRI contrast in the bowel. Other applications such as cancer therapy, ultrasound contrast and direct19FMR imaging continue to show promise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bajaj, A.K., M.A. Cobb, R. Virmani,et al.Limitation of myocardial reperfusion injury by intravenous perfluorochemicals.Circulation79: 645–656, 1989.

    Article  PubMed  CAS  Google Scholar 

  • Behan, M., D.O. O’Connell, R.F. Mattrey, and D.N. Carney Perfluoroctyl bromide as a contrast agent for CT and sonography: preliminary clinical results.Am.J. Radiol.160: 399–405, 1993.

    CAS  Google Scholar 

  • Beppu, S., H. Matsuda, T. Shishido,et al.Success of myocardial contrast echocardiography by peripheral venous injection method: visualization of area at risk.Circulation88: 1-401 [abstract], 1993.

    Google Scholar 

  • Blauth, C.I., P.L. Smith, J.V. Arnold,et al.Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass.J. Thorac. Cardiovasc. Surg.99: 61–69, 1990.

    PubMed  CAS  Google Scholar 

  • Brown, J. J., J.R. Duncan, J.P. Heiken,et al.Perfluorooctyl bromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon.Radiobiology181: 455–460, 1991.

    CAS  Google Scholar 

  • Bruneton, J.N., M.N. Falawese,et al.Liver, spleen and vessels: preliminary clinical results of CT with perfluorooctyl bromide.Radiology170: 179–183, 1989.

    PubMed  CAS  Google Scholar 

  • Cernaianu, A.C., R.K. Spence, T. Vasilidze,et al. Transfusion triggers with perflubron (Oxygent) in a canine model of surgical hemodilution. InFifth International Symposium on Blood Substitutes: New Frontiers (T. Chang, J.G. Riess and R.M. Winslow, eds.)

    Google Scholar 

  • Clark, L.C., J. Ackerman, S. Thomas,et al.Perfluoiinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen.Adv. Exp. Med. Biol.180: 835–846, 1985.

    Google Scholar 

  • Clark, L.C., and F. Gollan. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure.Science152: 1755–1756, 1966.

    Article  PubMed  CAS  Google Scholar 

  • Cleman, M., C.C. Jaffe, and D. Wholgelernter. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA-20%.Circulation74: 555–562, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Cotter, B.O. L. Kwan, B. Kimura,et al.Evaluation of the efficacy, safety and pharmacokinetics of QW3600 (Echogen) in man.Circulation90: 1–555, 1994.

    Google Scholar 

  • Dardzinski, B.J., and C.H. Sotak. Rapid tissue oxygen tension mapping using 19F inversion recovery echo planar imaging of perfluoro-15-crown-5-ether.Mag. Reson. Med.32: 88–97, 1994.

    Article  CAS  Google Scholar 

  • DeMaria, A.N., H. Dittrich, O.L. Kwan,et al.Myocardial opacification produced by peripheral venous injection of a new ultrasonic contrast agent.Circulation88: 1-401 [abstract], 1993.

    Google Scholar 

  • Eidelberg, D., G. Johnson, D. Barnes,et al.19F NMR imaging of blood oxygenation in the brain.Mag. Reson. Med.6: 344–352, 1988.

    Article  CAS  Google Scholar 

  • Evans, R.G., B.F. Kimler, R.A. Morantz, and R.A. Batnitzky. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade glioma.Int. J. Rad. Oncol. Bio. Phys.26: 649–652, 1989.

    Article  Google Scholar 

  • Flaim, S., D.R. Hazard, J. Hogan, and R.M. Peters. Characterization and mechanism of side-effects of Imagent BP (highly concentrated fluorocarbon emulsion) in swine.J. Invest. Radiol.26: S122–S124, 1991.

    CAS  Google Scholar 

  • Geyer, R.P., R.C. Monroe, and K. Taylor. Survival of rats totally perfused with a fluorocarbon-detergent preparation. InOrgan Perfusion and Preservation(J. Norman, ed.). New York: Appleton Century and Crofts, 1968, pp. 85–97.

    Google Scholar 

  • Glogar, D.H., R.A. Kloner, J. Muller,et al.Fluorocarbons reduce myocardial ischemic damage after coronary occlusion.Science211: 1439–1441, 1981.

    Article  PubMed  CAS  Google Scholar 

  • Goodin, T.H., E.G. Grossbard, R.J. Kaufman,et al.A perfluorochemical emulsion for prehospital resuscitatien of experimental hemorrhagic shock: a prospective, randomized controlled study.Crit. Care Med.22: 680–689, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Gould, S.A, A.L. Rosen, L.R. Sehgal,et al.Fluosol DA as a red-cell substitute in acute anemia.N. Eng. J. Med.314: 1653–1656, 1986.

    Article  CAS  Google Scholar 

  • Greenspan, J.S., M.R. Wolfson, D. Rubenstein, and T.H. Shaffer. Liquid ventilation of human preterm neonatesJ. Pediatrics117: 106–111, 1990.

    Article  CAS  Google Scholar 

  • Gruber, M., M. Prados, C. Russell,et al.Phase I/II study of Fluosol and oxygen in combination® with BCNU in malignant glioma.Proc. Am. Assoc. Cancer Res.31: 190, 1990.

    Google Scholar 

  • Hopkins, R. Personal communication, 1994.

    Google Scholar 

  • Jaffe, C.C., D. Wohlgelernter, H. Cabin,et al.Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.Am. Heart J.6: 1156–1164, 1988.

    Article  Google Scholar 

  • Joseph, P.M., Y. Yuasa, H.L. Kundel,et al.Magnetic resonance imaging of fluorine in rats infused with artificial blood.Invest. Radiol.20: 504–509, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kaufman, R.J. Medical oxygen transport using perfluorochemicals. In:Biotechnology of Blood (J. Goldstein, ed.). Boston: Butterworth-Heinemann, 1991, pp. 127–162.

    Google Scholar 

  • Kaufman, R.J. Perfluorochemical emulsions as blood substitutes. InEmulsions, a Fundamental and Practical Approach (J. Sjoblom, ed.). Boston: Kluwer Academic Publishers, 1992, pp. 207–226.

    Google Scholar 

  • Kaufman, R.J. The results of a Phase I clinical trial of a 40 v/v% emulsion of HM351 (Oxyfluor) in healthy human volunteers.Artif. Cells, Blood Substitutes, Immobil. Biotech.22: A112, 1994.

    Google Scholar 

  • Keipert, P. Use of Oxygent, a perfluorochemical (PFC) emulsion, as an antihypoxic agent to improve tissue oxygenation during acute blood loss. In:Blood Substitutes and Related Products: Advances in Development, Trial Design and Clinical Development( E. Scatchard and M. McBride, eds.) Southborough, MA: International Business Communications, 1994.

    Google Scholar 

  • Long, D.M., M.S. Liu, P.S. Szanto,et al.Efficacy and toxicity studies with radioopaque perfluorocarbon.Radiology133: 71, 1972a.

    Google Scholar 

  • Long, D.M., M.S. Liu, P.S. Szanto,et al.Forefront: preliminary communication–initial observations with a new x-ray contrast agent radioopaque perfluorocarbon.Rev. Surg.29: 71, 1972b.

    CAS  Google Scholar 

  • Long, D.M., F.K. Muiter, A.G. Greenburg,et al.Tumor imaging with x-rays using macrophage uptake of radioopaque fluorocarbon emulsions.Surgery84: 104–112, 1978.

    PubMed  CAS  Google Scholar 

  • Longmaid, H., D. Adams,et al.In vivo 19F NMR imaging of liver, tumor and abcesses in rats.Invest. Radiol.20: 141–145, 1985.

    Article  PubMed  CAS  Google Scholar 

  • Lustig, R., N. Mclntosh-Lowe, C. Rose,et al.Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.Int. J. Rad. Oncol. Biol. Phys.16: 1587–1593, 1989a.

    Article  CAS  Google Scholar 

  • Lustig, R., N. Lowe, L. Prosnitz,et al.Phase I/II study of Fluosol and 100% oxygen breathing as an adjuvant to radiation in the treatment of unresectable non-small cell carcinoma of the lung.Int. J. Rad. Oncol. Biol. Phys.17: 202, 1989b.

    Article  Google Scholar 

  • Mate, T.P., and S. Rockwell. Perfluorochemical emulsions do not affect bone marrow radiosensitivity. In:Abstracts, American Society Therapy Radiation Oncologists Meeting, Washington, D.C., Oct. 1984.

    Google Scholar 

  • Mattrey, R.F., F.W. Scheible, B.B. Gosink,et al.Perfluorooctyl bromide: a liver and spleen specific and a tumor imaging ultrasound contrast material.Radiology145: 759–762, 1982.

    PubMed  CAS  Google Scholar 

  • Mattrey, R.F., G.R. Leopold, E. vanSonneberg,et al.Perfluorochemicals as a liver and spleen seeking ultrasound contrast agent.J. Ultrasound Med.2: 173–176, 1983.

    PubMed  CAS  Google Scholar 

  • Mattrey, R.F., D.M. Long, R.A. Slutsky, and G.B. Higgins. Perfluorooctyl bromide as a blood pool contrast agent for liver, spleen and vascular imaging.J. Comput. Assist. Tombgr.8: 739–744, 1984.

    Article  CAS  Google Scholar 

  • Mattrey, R.F., G. Strich, R.E. Shelton,et al.Perfluorochemicals as ultrasound contrast agents for tumor imaging and hepatosplenography: preliminary clinical results.Radiology163: 339–343, 1987.

    PubMed  CAS  Google Scholar 

  • Mattrey R.F., M.A. Trammert, J.J. Brown,et al.Oral contrast agents for magnetic resonance imaging.Invest. Radiol.26: S65–S66, 1991.

    Article  PubMed  Google Scholar 

  • Modell, J.H., E.J. Newby, and B.C. Ruiz. Long-term survival of dogs after breathing oxygenated fluorocarbon liquid.Fed. Proc.34: 312–320, 1970.

    Google Scholar 

  • Modell, J.H., H.W. Calderwood, B.C. Ruiz,et al.Liquid ventilation of primates.Chest69: 79–81, 1976.

    Article  PubMed  CAS  Google Scholar 

  • Moody, D.M., M.A. Bell, V.R. Challa,et al.Brain microemboli during cardiac surgery or aortography.Annu. Neurol .28: 477–486, 1990.

    Article  CAS  Google Scholar 

  • Nunn, G.R., G. Dance, J. Peters, and L.H. Cohn. Effect of fluorocarbon exchange transfusion on myocardial infarction in dogs.Am. J. Cardiol.52: 203–205, 1983.

    Article  PubMed  CAS  Google Scholar 

  • Riess, J.G., and M. Leblanc. Perfluoro compounds as blood substitutes.Angewande Chemie International Edition in English17: 621–634, 1978.

    Article  CAS  Google Scholar 

  • Riess, J.G. Reassessment of the criteria for the selection of perfluorochemicals for second generation blood substitutes: analysis of structure-property relationships.Artif. Organs8: 44–56, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Rose, CM., R. Lustig, N. Mcintosh, and BA. Teicher. A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck.Int. J. Rad. Oncol. Biol. Phys.12: 1325–1327, 1986.

    Article  CAS  Google Scholar 

  • Schweighardt, F.K., and D. Woo. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells.US Patent No. 4, 781, 676, 1988.

    Google Scholar 

  • Schweighardt, F.K. Perfluoro-crown ethers in fluorine magnetic resonance imaging.US PatentNo. 4,838, 274, 1989.

    Google Scholar 

  • Shaffer, T.H., and G.D. Moskowitz. Demand-controlled liquid ventilation of the lungs,J. Appi. Physiol.36: 208–213, 1974.

    CAS  Google Scholar 

  • Shaw P.J., D. Bates, N.E. Cartlidge,et al.Neurologic and neuropsychological morbidity following major surgery: comparison of coronary bypass and peripheral vascular surgery.Stroke18: 700–707, 1987.

    Article  PubMed  CAS  Google Scholar 

  • Sloviter, H., and T. Kamimoto. Erythrocyte substitute for perfusion of brain.Nature216: 458, 1967.

    Article  PubMed  CAS  Google Scholar 

  • Song, C.W., I. Lee, T. Kasegawa,et al.Increase in PO2 and radiosensitivity of tumors by Fluosol-DA(20%).Cancer Res. 47: 442–446, 1987.

    PubMed  CAS  Google Scholar 

  • Spears, R., J. Serur, D. Baim,et. al. Myocardial protection with Fluosol-DA during prolonged coronary balloon occlusion in the dog.Circulation 73:II -245 [abstract], 1983.

    Google Scholar 

  • Spence, R.K. Use of Oxygent, perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives. InBlood Substitutes and Related Products (E. Scatchard and M. McBride, eds.) Southborough, MA: International Business Communications, 1994.

    Google Scholar 

  • Spiess, B.D., R.J. McCarthy, K.J. Turnan, A.W. Woronowicz, EA Tool, and A.D. Ivanovich. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43).Undersea Biomed. Res.15: 31–37, 1988.

    PubMed  CAS  Google Scholar 

  • Taylor, K.M., J.V. Arnold, J. Fleming, A.C. Bird, E.G. Grossbard, and R.J. Kaufman. Cerebral protection during CPB using perfluorocarbon: a preliminary report. InSecond International Conference on the Brain and Cardiac Surgery. Key West FL [abstract], 1992.

    Google Scholar 

  • Teicher, B.A., and S. Rockwell. Increased efficacy of radiotherapy in mice treated with perfluorochemical emulsions plus oxygen.Am. Assoc. of Cancer Res. Abstract 25–28, 1983.

    Google Scholar 

  • Teicher, B.A., S.A. Holden, G. Ara,et al.A new concentrated perfluorochemical emulsion and carbogen breathing as a adjuvant to treatment with antitumor alkylating agents.J. Cancer Res. Clin. Oncol.118: 509–514, 1992.

    Article  PubMed  CAS  Google Scholar 

  • Tremper, K.K., G.M. Vercellotti, and D.E. Hammerschmidt. Hemodynamic profile of adverse clinical reactions to Fluosol DA 20%.Crit. Care Med.12: 428–431, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Wall, T.C., R.M. Califf, J. Blamkenship,et al.Intravenous Fluosol in the treatment of acute myocardial infarction.Circulation90: 114–126, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HemaGen / PFC, 11810 Borman Drive, 63146, St. Louis, Missouri, USA

    Robert J. Kaufman Ph.D.

Authors
  1. Robert J. Kaufman Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, University of California, 92161, San Diego, CA, USA

    R. M. Winslow

  2. School of Medicine, University of California, 92161, San Diego, CA, USA

    K. D. Vandegriff

  3. Department of Applied Mechanics and Engineering Sciences, University of California, 92161, San Diego, CA, USA

    M. Intaglietta

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Birkhäuser Boston

About this chapter

Cite this chapter

Kaufman, R.J. (1995). Clinical Development of Perfluorocarbon-based Emulsions as Red Cell Substitutes. In: Winslow, R.M., Vandegriff, K.D., Intaglietta, M. (eds) Blood Substitutes. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-2576-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2576-8_5

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-7587-9

  • Online ISBN: 978-1-4612-2576-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation